Current status and updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland
The availability of drugs such as thalidomide, bortezomib and lenalidomide changed the landscape in myeloma treatment and has extended the median survival up to 10 years with a substantial improvement in quality of life. This development prompted a Swiss expert panel to re-evaluate the current sta...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
SMW supporting association (Trägerverein Swiss Medical Weekly SMW)
2015-02-01
|
| Reeks: | Swiss Medical Weekly |
| Onderwerpen: | |
| Online toegang: | https://www.smw.ch/index.php/smw/article/view/2000 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|